Tweets
anti-MDA5+ amyopathic dermatomyositis (ADM) with ILD is severe and refractory. NEJM letter reports on 18 ADM Rx w/ tofacitinibs who showed better 6 mo survival (100% vs 78%) (P=0.04) and improved ferritin, FVC, DLCO, & CT Chest over time. https://t.co/lsVGPxChoO
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years ago
Can Febuxostat be given to Allopurinol Hypersensitivity? Such pts not included in registrations trials; yet many literature reports of no toxicity & rare cross-Rxn; PI says ULORIC indicated w/ intolerant to allopurinol, or when allopurinol Tx not advisable https://t.co/KG36Ls6VsI
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years ago
Its been FORTY years since the "House of God" by Samuel Shem changed your medical thinking, if not humor. Check out Dr. Len Calabrese's recollections of the books 40th anniversary & join his summer book club and add some commentary! https://t.co/L8wiGpWk42
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years ago
Its been 0 years since the "House of God" by Samuel Shem changed your medical thinking, if not humor. Check out Dr. Len Calabrese's recollections of the books 40th anniversary & join his summer book club and add some commentary! https://t.co/L8wiGpWk42
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years ago
Women in the OTIS Pregnancy Project (657 RA, 170 JIA vs 564 without autoimmune dz) - preterm delivery (PTD) was increased in RA & JIA (RR 2.09 & 1.81) vs control; maternal activity was assoc w/ PTD (ARR 1.58 & 1.52), steroids had a 2-5X risk of PTD https://t.co/bWIHz0s1PV
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years ago
10 question UK survey on the use of HCQ in 989 patients (71% SLE; 12% UCTD/MCTD, 5.2% skin lupus, 11.5% RA, SS, etc). Results: 56% never had HCQ side effects; 23% had AE that improved; 12% had AE currently & 8.6% stopped HCQ for AE. https://t.co/iqJl0eEPTg
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years ago
Its been 30-40 years since the "House of God" by Samuel Shem changed your medical thinking, if not humor. Check out Dr. Len Calabrese's recollections and call to join his summer book club and add some commentary!! https://t.co/L8wiGpWk42
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years ago
A review of 376 FDA advisory panels between 2008-15, finds that 22% of FDA’s final actions were discordant with an advisory panels recommendations (moreso w/ safety panels). Of these, 3/4 lead to more restrictive actions and 1/4 less restrictive decisions https://t.co/AK7KbwN2l5
Dr. John Cush @RheumNow ( View Tweet )
7 years ago
Analysis of 149 OA and 203 RA pts from Rush Univ Rheum Clinic showed the same disease burden (by RAPID3) betw OA & A at initial visits, but after 6 mos. RAPID3 was more improved in RA patients than OA patients (P < 0.001). https://t.co/fNQ2ncJScI
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years ago
Analysis #osteoarthritis clinical trials placebo response ratio (PRR) as the placebo to treatment effect size ratio. PRR was best for walking time/distance (0.30, 95% CI 0.16 to 0.43) and worst for PRO pain (0.44, 95% CI 0.23 to 0.65) https://t.co/4VorQdSIV2
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years ago
RheumNow Podcast is up! Discussing MAS, CBD, CCP in PsA, Cost savings w/ LLDAS, lupus pregnancy and no go on NGF. View here>> https://t.co/zUclX3ISIs or listen on iTunes or SoundCloud>> https://t.co/DVw7Trrh5r
Dr. John Cush @RheumNow ( View Tweet )
7 years ago
ER study from 2015-17 shows that among 456 #gout patients, 28.3%) received opioid at discharge; 80% of these were new. Average dose was 38mg morphine equivalent for a median of 8 days - more likely w/ polyarticular gout, hx diabetes & hx prior opioids https://t.co/xf2jD1i4hg
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years ago
Upadacitinib versus Placebo or Adalimumab in Patients with Rheumatoid Arthritis and an Inadequate Response to Methotrexate:- Arthritis & Rheumatology - second Jak to beat the gold standard!
Peter Nash @drpnash ( View Tweet )
7 years ago
Do biologics work in relapsing polychondritis? French cohort of 41 pts use 105 biologics (TNFi=60; TCZ 17; anakinra 15; RTX 7; ABA6). While 63% resp in 1st 6 mos (on pred!), a complete response rate was 19.0%. Steroid sparing variable, high infx rates. https://t.co/Ff9KULlKVD
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years ago
Swedish registry comparison of 541 PsA 40944 non-PsA pregnancies between 1997-2014, shows PsA pregnancies had increased risks for preterm birth (adj OR 1.63) and caesarean deliveries (OR 1.47), but no increased risks for pre-eclampsia, stillbirth https://t.co/L5GcNVbjgQ
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 1 month ago
